Stay updated on Naptumomab + Durvalumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Naptumomab + Durvalumab in Solid Tumors Clinical Trial page.

Latest updates to the Naptumomab + Durvalumab in Solid Tumors Clinical Trial page
- Check5 days agoChange DetectedAn updated revision entry labeled v3.7.0 was added to the record history, replacing the previous v3.6.6 and indicating the page was updated.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page history shows a new revision tag, updating from v3.6.5 to v3.6.6. This signals a new version of the record metadata rather than changes to the study details.SummaryDifference0.1%

- Check48 days agoChange DetectedThe Study Record History now shows the latest revision as v3.6.5, replacing the previous v3.6.4. This reflects a page revision update at the system level rather than a change to trial details.SummaryDifference0.1%

- Check62 days agoChange DetectedA new revision entry v3.6.4 was added to the Record History, reflecting an updated version of the study record. The previous revision v3.6.3 remains in history as a past version.SummaryDifference0.1%

- Check84 days agoChange DetectedThe record history now shows a new revision entry (v3.6.3) replacing the previous one (v3.6.2), updating the page's version state in the history log.SummaryDifference0.1%

- Check91 days agoChange DetectedRevision label updated from v3.6.0 to v3.6.2 on the page, indicating a minor software version update. This change is an internal platform update and does not modify the study data or its history.SummaryDifference0.1%

Stay in the know with updates to Naptumomab + Durvalumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Naptumomab + Durvalumab in Solid Tumors Clinical Trial page.